← Eichor
Study identifier: NCT06764563 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients

Condition: Multiple Sclerosis  ·  Sponsor: Tel-Aviv Sourasky Medical Center

PhaseNA
Planned participants140
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The role of dietary interventions in improving symptoms of multiple sclerosis (MS) is of high interest amongst patients and researchers, but data supporting this evidence are limited. Current evidence indicates that A higher Expanded Disability Status Scale (EDSS) score correlates with poor diet quality in patients with MS. Moreover, even though disease-modifying therapies (DMT) improve disease course and prognosis, MS patients report a lower quality of life (QoL) than people without illness. The Mediterranean diet (Med-Diet) is beneficial in preventing cardiovascular comorbidities, and outcomes of a decrease in inflammation processes are evident. Recent studies suggest that the Med-Diet might positively affect MS QoL, However, empirical evidence remains unclear, limiting the possibility of evidence-based nutritional recommendations. In the current study, we aim to investigate the effect of the Mediterranean diet on the quality of life of patients with MS. Methods: Randomized controlled trial among MS patients aged 18-70. The participants will be randomly assigned to two 1:1 ratio groups: The med-diet group and the control group (no intervention). The intervention will be carried out for six months with subsequent six-months follow-up. Nine nutrition sessions will be delivered to the intervention group by an expert registered clinical dietitian. Data will be collected at baseline, three months, six months, and 12 months, including the following: Demographic, Anthropometric…

This description comes directly from the study's public registry record.

Talk to the study team

Arnon Karni, MD  ·  +972-52-426-6733  ·  arnonk@tlvmc.gov.il

Hadas Hardoon, PhD candidate  ·  +972-52-356-2580  ·  aradhardoon1@mail.tau.ac.il

Always discuss trial participation with your own doctor first.

Locations (1)

Tel Aviv Sourasky medical centerTel Aviv, Israel, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06764563